nystatin NDC 23155-051

NDC codes

FDA NDC Directory

Product NDC (as listed)23155-051Labeler and product segments. Claims need a package NDC.

Product NDC at billing width23155-0051Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
23155-051-01	23155005101	100 TABLET, COATED in 1 BOTTLE (23155-051-01)Marketed from Oct 31, 2011

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): nystatin
Generic name (nonproprietary): nystatin
Active ingredients: Nystatin — 500000 [USP'U]/1
Dosage form: Tablet, Coated
Route: Oral
Labeler: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 062474
Marketing start: Oct 31, 2011
Listing expires: Dec 31, 2026
Other FDA classes: Polyenes (Chemical structure)
Identifiers: Product ID 23155-051_d5c4ffad-b502-4226-9ff2-8603aac88dbaSPL ID d5c4ffad-b502-4226-9ff2-8603aac88dbaSPL set ID e87b8480-987d-4f82-87bf-cf831d6984a1RxCUI 312059UNII BDF1O1C72EUPC 0323155051018
Pharmacologic class: Polyene Antifungal

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N423155005101 followed by a unit qualifier and the quantity

Package 23155-0051-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 23, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Nystatin tablets are intended for the treatment of non-esophageal mucus membrane gastrointestinal candidiasis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 062474

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 062474
Product	Strength	Form · route	Labeler	Product NDC
nystatin	Nystatin 500000 [USP'U]/1	Tablet, CoatedOral	Proficient Rx LP	71205-575
Nystatin	Nystatin 500000 [USP'U]/1	Tablet, Film coatedOral	Chartwell RX, LLC	62135-741
nystatin	Nystatin 500000 [USP'U]/1	Tablet, CoatedOral	Bryant Ranch Prepack	63629-8350
nystatin	Nystatin 500000 [USP'U]/1	Tablet, CoatedOral	NuCare Pharmaceuticals,Inc.	68071-3508
nystatin	Nystatin 500000 [USP'U]/1	Tablet, CoatedOral	Preferred Pharmaceuticals Inc.	68788-8690